Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 128

1.

Modifying effects of δ-Aminolevulinate dehydratase polymorphism on blood lead levels and ALAD activity.

Mani MS, Kunnathully V, Rao C, Kabekkodu SP, Joshi MB, D'Souza HS.

Toxicol Lett. 2018 Oct 1;295:351-356. doi: 10.1016/j.toxlet.2018.07.014. Epub 2018 Jul 17.

PMID:
30025905
2.

Influence of gestational diabetes on the activity of δ-aminolevulinate dehydratase and oxidative stress biomarkers.

Rodrigues F, de Lucca L, Neme WS, Gonçalves TL.

Redox Rep. 2018 Dec;23(1):63-67. doi: 10.1080/13510002.2017.1402981. Epub 2017 Nov 17.

PMID:
29148924
3.

A new model of the mechanism underlying lead poisoning: SNPs in miRNA target region influence the δ-aminolevulinic acid dehydratase expression level.

Li C, Wang M, Wang Y, Zhang J, Sun N.

Epigenomics. 2017 Nov;9(11):1353-1361. doi: 10.2217/epi-2016-0180. Epub 2017 Sep 29.

PMID:
28960093
4.

Downregulation of delta-aminolevulinate dehydratase is associated with poor prognosis in patients with breast cancer.

Ge J, Yu Y, Xin F, Yang ZJ, Zhao HM, Wang X, Tong ZS, Cao XC.

Cancer Sci. 2017 Apr;108(4):604-611. doi: 10.1111/cas.13180. Epub 2017 Apr 12.

5.

Delta-aminolevulinate dehydratase activity and oxidative stress markers in preeclampsia.

de Lucca L, Rodrigues F, Jantsch LB, Kober H, Neme WS, Gallarreta FMP, Gonçalves TL.

Biomed Pharmacother. 2016 Dec;84:224-229. doi: 10.1016/j.biopha.2016.09.033. Epub 2016 Sep 19.

PMID:
27657831
6.

Association between delta-aminolevulinic acid dehydratase polymorphism and placental lead levels.

Kayaaltı Z, Sert S, Kaya-Akyüzlü D, Söylemez E, Söylemezoğlu T.

Environ Toxicol Pharmacol. 2016 Jan;41:147-51. doi: 10.1016/j.etap.2015.11.017. Epub 2015 Dec 3.

PMID:
26701682
7.

Relationship among maternal blood lead, ALAD gene polymorphism and neonatal neurobehavioral development.

Yun L, Zhang W, Qin K.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):7277-81. eCollection 2015.

8.

Genome-wide association study of blood lead shows multiple associations near ALAD.

Warrington NM, Zhu G, Dy V, Heath AC, Madden PA, Hemani G, Kemp JP, Mcmahon G, St Pourcain B, Timpson NJ, Taylor CM, Golding J, Lawlor DA, Steer C, Montgomery GW, Martin NG, Davey Smith G, Evans DM, Whitfield JB.

Hum Mol Genet. 2015 Jul 1;24(13):3871-9. doi: 10.1093/hmg/ddv112. Epub 2015 Mar 27.

9.

Delta-aminolevulinic acid dehydratase (ALAD) polymorphism in lead exposed Bangladeshi children and its effect on urinary aminolevulinic acid (ALA).

Tasmin S, Furusawa H, Ahmad SA, Faruquee MH, Watanabe C.

Environ Res. 2015 Jan;136:318-23. doi: 10.1016/j.envres.2014.08.045. Epub 2014 Nov 25.

PMID:
25460652
10.

δ-Aminolevulinate dehydratase activity in lung cancer patients and its relationship with oxidative stress.

Zanini D, Pelinson LP, Schmatz R, Belmonte Pereira L, Curry Martins C, Baldissareli J, Pires Amaral G, Antunes Soares FA, Brenner Reetz LG, Araújo Mdo C, Chiesa J, Morsch VM, Bitencourt Rosa Leal D, Schetinger MR.

Biomed Pharmacother. 2014 Jun;68(5):603-9. doi: 10.1016/j.biopha.2014.04.005. Epub 2014 Apr 28.

PMID:
24855033
11.
12.

Case-only gene-environment interaction between ALAD tagSNPs and occupational lead exposure in prostate cancer.

Neslund-Dudas C, Levin AM, Rundle A, Beebe-Dimmer J, Bock CH, Nock NL, Jankowski M, Datta I, Krajenta R, Dou QP, Mitra B, Tang D, Rybicki BA.

Prostate. 2014 May;74(6):637-46. doi: 10.1002/pros.22781. Epub 2014 Feb 5.

13.

Influence of delta-aminolevulinic acid dehydratase gene polymorphism on selected lead exposure biomarkers in a cohort of ex-smelter workers.

Leroyer A, Leleu B, Dehon B, Frimat P, Broly F, Nisse C.

J Toxicol Environ Health A. 2013;76(15):895-906. doi: 10.1080/15287394.2013.824843.

PMID:
24156693
14.

Effects of delta-aminolevulinic acid dehydratase polymorphisms on susceptibility to lead in Han subjects from southwestern China.

Yang Y, Wu J, Sun P.

Int J Environ Res Public Health. 2012 Jul;9(7):2326-38. doi: 10.3390/ijerph9072326. Epub 2012 Jul 2.

15.

Genotyping an ALAD polymorphism with real-time PCR in two populations from the Iberian Peninsula.

Moreira AO, Almeida A, Costa S, Laffon B, García-Léston J, Pásaro E, Méndez J, Teixeira JP.

Biochem Genet. 2012 Aug;50(7-8):560-4. doi: 10.1007/s10528-012-9500-x.

PMID:
22298357
16.

Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.

van Bemmel DM, Boffetta P, Liao LM, Berndt SI, Menashe I, Yeager M, Chanock S, Karami S, Zaridze D, Matteev V, Janout V, Kollarova H, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Slamova A, Rothman N, Han SS, Rosenberg PS, Brennan P, Chow WH, Moore LE.

PLoS One. 2011;6(7):e20432. doi: 10.1371/journal.pone.0020432. Epub 2011 Jul 20.

17.

δ-Aminolevulinate dehydratase activity in type 2 diabetic patients and its association with lipid profile and oxidative stress.

Bonfanti G, Ceolin RB, Valcorte T, De Bona KS, de Lucca L, Gonçalves TL, Moretto MB.

Clin Biochem. 2011 Sep;44(13):1105-1109. doi: 10.1016/j.clinbiochem.2011.06.980. Epub 2011 Jul 6.

PMID:
21762684
18.

δ-Aminolevulinic acid dehydratase genotype predicts toxic effects of lead on workers' peripheral nervous system.

Zheng G, Tian L, Liang Y, Broberg K, Lei L, Guo W, Nilsson J, Bergdahl IA, Skerfving S, Jin T.

Neurotoxicology. 2011 Aug;32(4):374-82. doi: 10.1016/j.neuro.2011.03.006. Epub 2011 Mar 23.

PMID:
21439310
19.

Lead exposure suppressed ALAD transcription by increasing methylation level of the promoter CpG islands.

Li C, Xu M, Wang S, Yang X, Zhou S, Zhang J, Liu Q, Sun Y.

Toxicol Lett. 2011 May 30;203(1):48-53. doi: 10.1016/j.toxlet.2011.03.002. Epub 2011 Mar 9.

PMID:
21396434
20.

Blood lead levels, ALAD gene polymorphisms, and mortality.

van Bemmel DM, Li Y, McLean J, Chang MH, Dowling NF, Graubard B, Rajaraman P.

Epidemiology. 2011 Mar;22(2):273-8. doi: 10.1097/EDE.0b013e3182093f75.

Supplemental Content

Support Center